BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

IMULAN BioTherapeutics and ONCURA Establish New Cancer Program


6/17/2009 1:43:58 PM

Bookmark and Share

St. Joseph, MO. –Imulan BioTherapeutics, LLC (IMULAN) and Oncura Partners announced formation of a personalized cancer program aimed at creating a patient specific approach to tumors. IMULAN’s is using their apSTAR laser technology, for Autologous Patient Specific Tumor Antigen Response, to create a network of apSTAR centers. apSTAR works by stimulating a patient specific response against tumor cells, thereby creating tumor immunity and improving the rate of primary and metastatic regression. IMULAN recently licensed the global veterinary rights to apSTAR from ImmunoPhotonics, Inc, leading to the creation of IMULAN’s new division, Veterinary Cancer Therapeutics (www.VetCancer.com).

Dr. Craig Woods, CEO of Imulan and Veterinary Cancer Therapeutics, stated, “We are delighted to work with Oncura Partners on this exciting new technology. Their pre-established oncology network combined with a progressive, forward looking approach to oncology will facilitate our ability to design new patient specific treatment protocols for veterinary cancer patients. Oncura Partners shares the same vision as IMULAN, which is to improve the treatment success of veterinary cancer patients."

Dr. Brian Huber, President of Oncura Partners, stated, “We are excited about apStAR’s potential to truly make a difference in the lives of pets battling cancer. This unique approach to fighting cancer is where all the scientific research has been focused, using the patients immune system to fight the primary and metastatic cancer cells. We are privileged to partner with such a forward thinking company as Imulan BioTherapeutics."

About Oncura Partners: Oncura Partners is a company dedicated to helping veterinary practitioners manage oncology cases, as well as other chronic health conditions in pets. Oncura’s unique partnership with the practitioner, specialist, pharmacies, in combination with a proprietary online medical record system, creates an efficient way for hospitals to improve overall medical management and patient compliance. Oncura focuses on raising the bar for all case management processes and help busy doctors accomplish this in their day to day practice setting. Oncura offers complete case management services at www.oncurapartners.com.

About Imulan: Imulan develops unique, precision immune regulating compounds for veterinary medicine. IMULAN is located in St. Joseph, MO and has diversified into biologics, vaccines, nutritionals, and medical devices to accommodate a growing demand for improved ways of treating disease. In addition, IMULAN has a growing laboratory service focused on immunology and tumor biology. For more information, visit www.IMULAN.com or www.VetCancer.com.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES